Pharma major Glenmark's Ankleshwar plant gets EIR report from USFDA

The stock was trading at Rs 905, up 1.58 per cent from its previous close on BSE

Glenmark office
Glenmark office
Press Trust of India New Delhi
Last Updated : Mar 15 2017 | 11:30 AM IST

Don't want to miss the best from Business Standard?

Drug firm Glenmark has received establishment inspection report (EIR) from the US health regulator on closure of inspection of its Ankleshwar plant in Gujarat, the company said today.

"Glenmark would like to state that its Ankleshwar plant received the EIR (establishment inspection report) yesterday. The EIR is issued by the FDA only if it finds the facility to be deemed acceptable," it said in a BSE filing.

The USFDA releases a copy of the EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.

Also Read

Glenmark was clarifying to the stock exchanges over a news report which claimed that its Ankleshwar plant received observations from the USFDA during its inspection in December 2016.

The stock was trading at Rs 905, up 1.58 per cent from its previous close on BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 15 2017 | 11:13 AM IST

Next Story